Strides Arcolab Limited (Strides) is a global pharmaceutical company. Strides develops and manufactures a range of intellectual property (IP)-led pharmaceutical products. It has two divisions: Specialty (Agila) and Pharmaceuticals. As of December 31, 2011, it had 14 manufacturing facilities across five locations, a research and development (R&D) hub in Bangalore, and a marketing network spanning 75 countries. On January 1, 2011, it acquired Agila Marketing e Distribuicao de Productos Hospitalares Ltda and Agila Especialidades Farmaceuticas Ltda. Two facilities in Bangalore, India received the United States Food & Drug Administration (FDA) approvals, during the year ended December 31, 2011. The Brazilian Sterile Penems Facility received US FDA approval, in February 2012. On January 24, 2012, it sold its investments in Ascent Pharmahealth Limited. In December 2013, Mylan Inc completed the acquisition of the Agila injectables businesses from Strides Arcolab Ltd.